WallabyPhenox today announced the successful treatment of the first U.S. patient in the p48 and p64 MW HPC in Aneurysm Occlusion (PIANO) IDE trial, evaluating the p48 and p64 MW HPC Flow Modulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results